Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

INTERVENTIONALInicio: 20 de dic de 2023ID: NCT05912517

ReclutandoFase 3ClinicalTrials.gov

16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase

INTERVENTIONALInicio: 31 de dic de 2018ID: NCT03747458

ReclutandoClinicalTrials.gov

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

OBSERVATIONALInicio: 1 de oct de 2016ID: NCT02848274

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)

INTERVENTIONALInicio: 25 de feb de 2025ID: NCT06747949

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase

INTERVENTIONALInicio: 7 de feb de 2025ID: NCT06744920

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic Obstructive And Non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)

INTERVENTIONALInicio: 24 de sept de 2024ID: NCT06481891

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy

INTERVENTIONALInicio: 13 de dic de 2022ID: NCT05648500

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

INTERVENTIONALInicio: 24 de nov de 2025ID: NCT07286175

ReclutandoClinicalTrials.gov

Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)

OBSERVATIONALInicio: 1 de jul de 2024ID: NCT06573723

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) With Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3)

INTERVENTIONALInicio: 28 de sept de 2025ID: NCT07028853

ReclutandoFase 3ClinicalTrials.gov

TENACITY - A Phase III, Prospective, Randomized, Open-label, Blinded Endpoint Assessment (PROBE) to Assess Efficacy and Safety of i.v. Tenecteplase vs Standard of Care in Patients With Acute Ischemic Stroke (Including Wake-up Stroke), Last Known Well >4.5 h With Imaging Evidence of Salvageable Ischemic Tissue

INTERVENTIONALInicio: 17 de feb de 2026ID: NCT07361302

ReclutandoFase 2ClinicalTrials.gov

A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of Oral VH4524184 Coadministered With Emtricitabine and Tenofovir Alafenamide in Treatment Naive Viremic Persons With HIV-1 (INNOVATE Study)

INTERVENTIONALInicio: 11 de feb de 2026ID: NCT07202546

ReclutandoFase 3ClinicalTrials.gov

Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.

INTERVENTIONALInicio: 12 de feb de 2020ID: NCT04088396

ReclutandoFase 3ClinicalTrials.gov

A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

INTERVENTIONALInicio: 24 de ene de 2024ID: NCT06225596

ReclutandoClinicalTrials.gov

Institutional Registry of Hip Fracture in the Elderly

OBSERVATIONALInicio: 1 de nov de 2016ID: NCT02279550

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

INTERVENTIONALInicio: 21 de nov de 2024ID: NCT06617325

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Budoprutug (TNT119) in Subjects With Primary Membranous Nephropathy (PMN)

INTERVENTIONALInicio: 25 de ago de 2025ID: NCT07096843

ReclutandoFase 3ClinicalTrials.gov

IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy

INTERVENTIONALInicio: 5 de nov de 2025ID: NCT07100080

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction

INTERVENTIONALInicio: 1 de dic de 2025ID: NCT07288398

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma

INTERVENTIONALInicio: 30 de ago de 2023ID: NCT06052267